Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
As clean energy goals rise, two small modular reactor players, Oklo and NuScale Power, stand out. This guide breaks d...
Could Monero surpass Cardano by 2028? This article lays out the pathways, risks, and strategies for investors trackin...
As AI and data demand surge, investors eye NuScale Power and the small modular reactor trend. Can nuscale power next ...
Fresh demand signals and disciplined supply dynamics are setting up Micron stock for potential upside. This guide bre...
Iran slams U.S. strikes drew an immediate market response, with oil prices edging higher and risk assets tightening a...
Two very different tech plays collide in 2026: Innodata edges into AI data preparation, while Workiva anchors large e...
Constellation Energy stock climbing today reflects a mix of solid quarterly results and favorable energy-market dynam...
TD Cowen warns that bills advancing prediction markets face a tough path in Congress this year, citing bipartisan con...
Intuitive Machines has captured investor attention as space missions gain traction. This guide breaks down the main d...
SpaceX captures headlines with bold tech and presumed multi-bagger upside. Still, the stock question isn’t simple. Th...